Influence of age and comedication on steady-state clonazepam serum level–dose ratios in Japanese epileptic patients

Authors: Yukawa E.; Satou M.; Nonaka T.; Yukawa M.; Ohdo S.; Higuchi S.; Kuroda T.; Goto Y.

Source: Journal of Clinical Pharmacy & Therapeutics, Volume 26, Number 5, October 2001 , pp. 375-379(5)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Abstract:

Background: In antiepileptic drugs, the marked inter- and intrapatient variability of the level–dose ratio makes it difficult to predict serum concentrations from the administered per kg dose. It is therefore important to identify factors, such as age and comedication, that could contribute to this observed variability.

Objective: To investigate the effect of age and comedication on clonazepam (CZP) level–dose (L/D) ratios.

Method: A retrospective evaluation of data from 137 epileptic patients who had received clonazepam.

Results: The CZP L/D ratio increased slowly with age up to 15 years in patients on monotherapy. Associated antiepileptic therapy affected the CZP L/D ratio, which was significantly reduced in patients on polytherapy as compared to patients on monotherapy.

Conclusion: The study therefore suggests that routine monitoring of CZP serum levels is extremely useful, especially in the paediatric age group, and in patients who require associated antiepileptic medication.

Keywords: antiepileptic drug; carbamazepine; clonazepam; drug interaction; valproic acid

Language: English

Document Type: Miscellaneous

Publication date: 2001-10-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page